SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
154.40    1.60 (1.05%)
Bid:
154.40
Ask:
154.80
Spread: 0.40 (0.259%)
Market Cap: £883.65m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Q3 Trading Update

28 Oct 2020 07:00

RNS Number : 3962D
Elementis PLC
28 October 2020
 

Elementis plc

Q3 Trading Update

Resilient performance, in line with management expectations

On track for significant year end net debt reduction

Elementis plc ("Elementis" or the "Group"), a global specialty chemicals company, today issues a trading update for the three months ended 30 September 2020.

Third quarter business performance

 

While trading improved versus the second quarter, COVID-19 continues to impact the Group with volumes down approximately 13% on the prior year. Pricing remained resilient across all businesses except for Chromium. As a result of cost savings and supply chain efficiencies, overall performance in the third quarter was in line with management expectations.

· Coatings performed well in Q3, with revenue broadly in line with the prior year period, as continued resilience in decorative applications was supported by improved industrial demand. The business remains on track for improved operating margins versus the prior year.

 

· Personal Care sales were materially lower than both the prior year period and Q2, particularly in higher margin cosmetics, due to the continuation of social and travel restrictions as a result of COVID-19.

 

· Talc volumes recovered from the Q2 trough but as expected were below prior year. Automotive demand sequentially improved and coatings gained market share.

· Chromium performance was in line with Q2 levels, but materially down on the prior year period, reflective of lower demand at key customers and sustained industry pricing pressure, particularly in the rest of the world. Current Q4 trading indicates some recovery versus a difficult Q3.

 

· Energy continues to experience very weak market conditions with rig counts and activity levels remaining at subdued Q2 levels.

 

In the third quarter we have continued to successfully deliver against our Innovation, Growth and Efficiency strategy. We launched 3 new products, delivered $9m of new business and remain on track for delivery of $15m in year cost savings.

For 2021, our new business and innovation pipelines are encouraging, and we have made good progress underpinning $10m of supply chain cost efficiencies. Our new AP Actives plant in India remains on track for mid-2021 start up.

Liquidity and balance sheet

 

Elementis has a proven cash generative business model, with average operating cash conversion above 90% over the last 3 years and the Group is on track to deliver a significant reduction in net debt by year end.

 

The Group continues to operate with ample liquidity, with over $300m immediately available through committed lending facilities. As announced in September, the relaxation of the Group net debt/EBITDA* banking covenant to 3.75x, agreed in Q1 2020 as part of the Group's response to COVID19, has now been extended, at minimal cost, to include the two testing points in 2021 (i.e. 30 June and 31 December).

 

Outlook

 

Whilst market conditions remain challenging and future visibility is limited, we have seen solid demand in October and have a robust order book for November. We have a clear, focused strategy and we continue to tightly manage the business in terms of fixed costs and working capital to address changes in demand. An action plan to improve the financial performance of Energy is underway.

 

 

Commenting on the performance, CEO, Paul Waterman said,

"Overall performance has been resilient and in line with our expectations. Nevertheless, the macroeconomic outlook remains uncertain and our focus remains on managing our operations well and executing our growth, innovation and efficiency agenda.

In recent years we have focused Elementis on high quality, high margin activities in Personal Care, Coatings and Talc as these businesses have enduring positions of strength in structural growth markets. I am confident we will emerge from this crisis well positioned for improved top and bottom line performance and future value creation."

 

Enquiries

Elementis plc

James Curran, Investor Relations Tel: 020 7067 2994

 

Tulchan

Martin Robinson Tel: 020 7353 4200

David Allchurch

 

 

Note: * Pre IFRS 16

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMRBRTMTITBJM
Date   Source Headline
12th Nov 20209:39 amRNSResponse to Minerals Technologies Inc announcement
12th Nov 20207:51 amRNSStatement re Possible Offer
9th Nov 20204:55 pmRNSHolding(s) in Company
28th Oct 20207:00 amRNSQ3 Trading Update
26th Oct 20207:00 amRNSUpdate on 2020 AGM resolution vote
16th Oct 20207:00 amRNSDirectorate Change
17th Sep 202012:40 pmRNSDirector/PDMR Shareholding
7th Sep 20207:00 amRNSCovenant update
1st Sep 20202:22 pmRNSBlock listing Interim Review
28th Jul 20207:00 amRNSHalf-year Report
8th Jun 20204:28 pmRNSHolding(s) in Company
15th May 20201:08 pmRNSHolding(s) in Company
1st May 20209:56 amRNSTotal Voting Rights
29th Apr 202011:02 amRNSDirector Declaration
29th Apr 202010:49 amRNSResult of AGM
29th Apr 20207:00 amRNSAGM Trading Statement
28th Apr 202012:06 pmRNSDisclosure of rights attached to equity shares
21st Apr 20207:00 amRNSAGM update
8th Apr 202011:50 amRNSDirector/PDMR Shareholding
2nd Apr 20202:51 pmRNSHolding(s) in Company
1st Apr 20208:13 amRNSDirector Declaration
25th Mar 20204:04 pmRNSAnnual Financial Report
25th Mar 202010:19 amRNSHolding(s) in Company
24th Mar 20209:02 amRNSHolding(s) in Company
23rd Mar 20205:25 pmRNSHolding(s) in Company
20th Mar 20205:28 pmPRNDirector/PDMR Shareholding
20th Mar 20205:07 pmRNSDirector/PDMR Shareholding
20th Mar 20205:06 pmRNSDirector/PDMR Shareholding
20th Mar 202010:44 amRNSHolding(s) in Company
19th Mar 20204:28 pmRNSDirector/PDMR Shareholding
19th Mar 20204:25 pmRNSDirector/PDMR Shareholding
19th Mar 20204:24 pmRNSDirector/PDMR Shareholding
19th Mar 20207:00 amPRNCOVID-19 update
18th Mar 20203:14 pmRNSAdditional Listing
17th Mar 202010:25 amRNSDirector/PDMR Shareholding
12th Mar 202010:36 amRNSDirector/PDMR Shareholding
10th Mar 20202:02 pmRNSDirector/PDMR Shareholding
9th Mar 202010:57 amRNSDirector/PDMR Shareholding
6th Mar 20202:36 pmRNSDirector/PDMR Shareholding
6th Mar 20202:35 pmRNSDirector/PDMR Shareholding
5th Mar 20201:41 pmRNSDirector/PDMR Shareholding
4th Mar 20207:00 amRNS2019 Preliminary Results Announcement
2nd Mar 20203:46 pmRNSBlock listing Interim Review
2nd Mar 202011:22 amPRNTotal Voting Rights
4th Feb 20207:00 amRNSDirectorate Change
21st Jan 20208:46 amPRNDirector Declaration
20th Jan 202010:54 amPRNHolding(s) in Company
14th Jan 20207:00 amRNSTrading update
6th Jan 202010:09 amPRNHolding(s) in Company
2nd Jan 202011:12 amPRNTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.